Tower Research Capital LLC (TRC) - ERYTECH PHARMA ownership

ERYTECH PHARMA's ticker is ERYP and the CUSIP is 29604W108. A total of 10 filers reported holding ERYTECH PHARMA in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of ERYTECH PHARMA
ValueSharesWeighting
Q4 2021$1,000
-50.0%
321
+7.4%
0.00%
Q3 2021$2,0002990.00%
Other shareholders
ERYTECH PHARMA shareholders Q4 2021
NameSharesValueWeighting ↓
StoneX Group Inc. 17,304$130.00%
Baader Bank Aktiengesellschaft 24,000$14,7160.00%
Vanguard Personalized Indexing Management, LLC 24,271$18,6890.00%
Citadel Advisors 400$2920.00%
Citadel Advisors 16,606$12,1220.00%
Asset Dedication, LLC 4,000$30.00%
Ikarian Capital, LLC 3,019$2,2570.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 10,590$7,7310.00%
MILLENNIUM MANAGEMENT LLC 12,069$8,8100.00%
View complete list of ERYTECH PHARMA shareholders